Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Influenza Vaccines × Lymphoid × Clear all

Phase

Phase 2 6 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Lymphoid 1 Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 1 Influenza, Human 1

Interventions

Cyclophosphamide 47 Rituximab 34 Exercise 25 fludarabine phosphate 24 Methotrexate 24 Blood Specimen Collection 23 Vincristine 21 Radiotherapy 21 Cytarabine 21 Filgrastim 19 Peripheral Blood Stem Cell Transplantation 18 Whole-Body Irradiation 17 Prednisone 16 Melphalan 16 Etoposide 16 Cyclosporine 16 Methods 15 Dexamethasone 15 Busulfan 15 Antilymphocyte Serum 15 fludarabine 14 Doxorubicin 14 Educational Status 13 Mycophenolic Acid 12 Magnetic Resonance Spectroscopy 11 Early Intervention, Educational 11 Therapeutics 10 Surveys and Questionnaires 9 Standard of Care 9 Prednisolone 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01707628 2014-01-31

Rituxivac

St. Antonius Hospital

Phase NA Completed

Influenza, Human, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡